Ackman says Valeant stock 'extraordinary bargain'

November 9, 2015 12:25 PM EST

(Reuters) - Activist investor Bill Ackman said Valeant Pharmaceuticals International Inc's (NYSE: VRX) (NYSE: VRX) stock was an "extraordinary bargain" given its low price.

More doctors could use specialty pharmacies, potentially benefiting Valeant, and the selloff in the stock was unwarranted, Ackman said on Pershing Square's quarterly call on Monday.

He also said he had constructive meeting with the management of Mondelez International Inc (NASDAQ: MDLZ), in which he took a stake in August.

(Reporting by Sruthi Ramakrishnan in Bengaluru; Editing by Sriraj Kalluvila)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hedge Funds, Insiders' Blog, Reuters, Short Sales

Related Entities

William Ackman, Pershing Square Capital